RUNX2 and lung carcinoma: In our lung cancer bioinformatic analysis of TF RUNX2 (Otálora-Otálora et al., 2022a), we analyzed and compared our pipeline and results (Otálora-Otálora et al., 2019, Otálora-Otálora et al., 2022b) with previous studies, finding eleven publications assessing the lung cancer TRN with different microarray and RNA-Seq studies, and performing direct and very different bioinformatics analyses on datasets created or selected from the databases.